| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |